Granahan Investment Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-10,260
| Closed | -$3.27M | – | 209 |
|
|
2021
Q1 | $3.27M | Sell |
10,260
-2,792
| -21% | -$890K | 0.07% | 158 |
|
|
2020
Q4 | $4.23M | Buy |
+13,052
| New | +$4.23M | 0.1% | 141 |
|
|
2020
Q3 | – | Sell |
-3,802
| Closed | -$919K | – | 208 |
|
|
2020
Q2 | $919K | Sell |
3,802
-17,836
| -82% | -$4.31M | 0.03% | 170 |
|
|
2020
Q1 | $3.14M | Buy |
21,638
+12,911
| +148% | +$1.87M | 0.17% | 110 |
|
|
2019
Q4 | $1.49M | Sell |
8,727
-376
| -4% | -$64.2K | 0.07% | 148 |
|
|
2019
Q3 | $1.62M | Sell |
9,103
-11,097
| -55% | -$1.97M | 0.09% | 145 |
|
|
2019
Q2 | $5.26M | Sell |
20,200
-599
| -3% | -$156K | 0.26% | 85 |
|
|
2019
Q1 | $5.94M | Buy |
20,799
+13,334
| +179% | +$3.81M | 0.32% | 84 |
|
|
2018
Q4 | $2.43M | Buy |
+7,465
| New | +$2.43M | 0.17% | 120 |
|
|
2018
Q2 | – | Sell |
-12,317
| Closed | -$3.58M | – | 227 |
|
|
2018
Q1 | $3.58M | Sell |
12,317
-72,245
| -85% | -$21M | 0.26% | 113 |
|
|
2017
Q4 | $15.8M | Sell |
84,562
-48,373
| -36% | -$9.07M | 1.25% | 19 |
|
|
2017
Q3 | $22.4M | Sell |
132,935
-7,451
| -5% | -$1.26M | 1.87% | 6 |
|
|
2017
Q2 | $20.1M | Buy |
140,386
+19,421
| +16% | +$2.78M | 1.85% | 8 |
|
|
2017
Q1 | $15.1M | Sell |
120,965
-451,718
| -79% | -$56.6M | 1.52% | 11 |
|
|
2016
Q4 | $64.5M | Buy |
572,683
+271,600
| +90% | +$30.6M | 2.22% | 1 |
|
|
2016
Q3 | $38.7M | Sell |
301,083
-20,700
| -6% | -$2.66M | 1.27% | 13 |
|
|
2016
Q2 | $35.2M | Sell |
321,783
-600
| -0.2% | -$65.6K | 1.28% | 10 |
|
|
2016
Q1 | $30.6M | Buy |
322,383
+33,400
| +12% | +$3.17M | 1.11% | 17 |
|
|
2015
Q4 | $26.1M | Buy |
288,983
+211,675
| +274% | +$19.1M | 0.9% | 30 |
|
|
2015
Q3 | $7.17M | Buy |
77,308
+38,808
| +101% | +$3.6M | 0.22% | 146 |
|
|
2015
Q2 | $2.53M | Buy |
+38,500
| New | +$2.53M | 0.07% | 207 |
|